Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park(Centre Hospitalier Universitaire de Grenoble), Didier Bouscary(Université Paris Cité), Alexa S. Green(Délégation Paris 5), Patrick Mayeux(Université Paris Cité), Pascale Cornillet‐Lefèbvre(Centre Hospitalier Universitaire de Reims), Nicolas Chapuis(Délégation Paris 5), Valérie Bardet(Délégation Paris 5), Jérôme Tamburini(Centre National de la Recherche Scientifique), C. Lacombe(Délégation Paris 5), Lise Willems(Hôpital Cochin)
Cited by 316
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma
|Oncogene|2002|298